XML 22 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Deferred Stock Units
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interest
Balance beginning of period (in shares) at Dec. 31, 2018   105,087            
Balance beginning of period at Dec. 31, 2018 $ (9,233) $ 10,509 $ 1,138,216 $ 4,524 $ 1,167,928 $ (41,791) $ (2,288,899) $ 280
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 102,709       102,681     28
Other comprehensive loss, net 1,776         1,776    
Repurchases of common stock, net (61,135)           (61,135)  
Common stock issued under stock plans (in shares)   258            
Common stock issued under stock plans 11,419 $ 26 11,393          
Share-based compensation cost 6,334   6,266 68        
Balance end of period (in shares) at Mar. 31, 2019   105,345            
Balance end of period at Mar. 31, 2019 51,870 $ 10,535 1,155,875 4,592 1,270,609 (40,015) (2,350,034) 308
Balance beginning of period (in shares) at Dec. 31, 2018   105,087            
Balance beginning of period at Dec. 31, 2018 (9,233) $ 10,509 1,138,216 4,524 1,167,928 (41,791) (2,288,899) 280
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 228,410              
Other comprehensive loss, net 1,208              
Balance end of period (in shares) at Jun. 30, 2019   105,478            
Balance end of period at Jun. 30, 2019 171,549 $ 10,548 1,170,962 4,381 1,396,315 (40,583) (2,370,377) 303
Balance beginning of period (in shares) at Mar. 31, 2019   105,345            
Balance beginning of period at Mar. 31, 2019 51,870 $ 10,535 1,155,875 4,592 1,270,609 (40,015) (2,350,034) 308
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 125,701       125,706     (5)
Other comprehensive loss, net (568)         (568)    
Repurchases of common stock, net (20,343)           (20,343)  
Common stock issued under stock plans (in shares)   133            
Common stock issued under stock plans 7,991 $ 13 8,556 (578)        
Deferred stock units activity 0   (324) 324        
Share-based compensation cost 6,898   6,855 43        
Balance end of period (in shares) at Jun. 30, 2019   105,478            
Balance end of period at Jun. 30, 2019 $ 171,549 $ 10,548 1,170,962 4,381 1,396,315 (40,583) (2,370,377) 303
Balance beginning of period (in shares) at Dec. 31, 2019 105,711 105,711            
Balance beginning of period at Dec. 31, 2019 $ 177,825 $ 10,571 1,213,517 4,462 1,595,648 (46,182) (2,600,543) 352
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 111,856       111,827     29
Other comprehensive loss, net (9,064)         (9,064)    
Repurchases of common stock, net (187,767)           (187,767)  
Common stock issued under stock plans (in shares)   203            
Common stock issued under stock plans 9,750 $ 20 9,730          
Share-based compensation cost 7,284   7,238 46        
Balance end of period (in shares) at Mar. 31, 2020   105,914            
Balance end of period at Mar. 31, 2020 $ 108,055 $ 10,591 1,230,485 4,508 1,705,646 (55,246) (2,788,310) 381
Balance beginning of period (in shares) at Dec. 31, 2019 105,711 105,711            
Balance beginning of period at Dec. 31, 2019 $ 177,825 $ 10,571 1,213,517 4,462 1,595,648 (46,182) (2,600,543) 352
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 260,852              
Other comprehensive loss, net $ (10,850)              
Balance end of period (in shares) at Jun. 30, 2020 106,031 106,031            
Balance end of period at Jun. 30, 2020 $ 273,400 $ 10,603 1,247,456 5,402 1,854,586 (57,032) (2,788,052) 437
Balance beginning of period (in shares) at Mar. 31, 2020   105,914            
Balance beginning of period at Mar. 31, 2020 108,055 $ 10,591 1,230,485 4,508 1,705,646 (55,246) (2,788,310) 381
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 148,996       148,940     56
Other comprehensive loss, net (1,786)         (1,786)    
Issuances of common stock, net 258           258  
Common stock issued under stock plans (in shares)   117            
Common stock issued under stock plans 10,080 $ 12 10,068          
Deferred stock units activity 0   (894) 894        
Share-based compensation cost $ 7,797   7,797          
Balance end of period (in shares) at Jun. 30, 2020 106,031 106,031            
Balance end of period at Jun. 30, 2020 $ 273,400 $ 10,603 $ 1,247,456 $ 5,402 $ 1,854,586 $ (57,032) $ (2,788,052) $ 437